Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Addiction: early-phase trial registry
5 of 17 indexed Addiction trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,004 of 28,707 conditions by registered trial count.
17 US clinical trials · 5 currently recruiting · #1,004 of 28,707 conditions by registered trial count
Addiction: 17 US clinical trials tracked, 5 recruiting.
Addiction is the subject of 17 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Yale University, running 3 of these trials.
Enrollment posture brief
Registry condition addiction
OPEN 5 | RECR 29% | LATE 0 | EARLY 4 | RANK #1004 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Arthritis, Psoriatic (29% recruiting · 17 trials)
Addiction lists 5 open slots (29% of 17 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Addiction on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Addiction is recruiting below its size-band peers.
5 of 17 indexed trials (29.4%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Addiction research.
Yale University accounts for 3 of 17 trials (17.6%). 12 distinct sponsors appear on at least one study for this condition label.
-
Typical Addiction enrolment sits around 100 participants.
Median target enrolment is 100 among the 17 trials that report a genuine target (sentinel values excluded). 8 of those (47.1%) plan for fewer than 100 participants.
-
Addiction research is mostly interventional.
15 interventional and 2 observational studies make up this index (88.2% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
17 total, page 1 of 1
Behavioral and Functional Task Development, Implementation, and Testing
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NCT02108054
Syringe Service Based Telemedicine and Social Network Driven HIV Prevention Service Implementation
Johns Hopkins University
NCT06103370
Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics
Yale University
NCT06624137
Semaglutide Therapy for Alcohol Reduction (STAR)
National Institute on Drug Abuse (NIDA)
NCT06015893
Tdcs And cogNitive traininG cOmbined for AUD (TANGO)
University of Minnesota
NCT05062369
Peer Supported Collaborative Care Mental Health and Substance Use Disorder Care
Johns Hopkins University
NCT04601064
Group Activities to Support Addiction Recovery
University of Nebraska
NCT07071883
Breathwork-assisted Treatment for Cannabis Use Disorder
Elias Dakwar
NCT05219825
Screening Protocol for the Evaluation of Potential Research Subjects
National Institute on Drug Abuse (NIDA)
NCT01036971
Providing Mental Health Precision Treatment
University of Michigan
NCT04342494
An Addiction-Based Mobile Health Weight Loss Intervention With Coaching
Children's Hospital Los Angeles
NCT03500835
Perioperative Pregabalin in Ureteroscopy
University of Missouri-Columbia
NCT04122196
Journaling and Addiction Recovery: Piloting "Positive Recovery Journaling"
University of Minnesota
NCT04458181
Cognitive Effects of Atomoxetine in Humans: Genetic Moderators
Yale University
NCT01498549
Comprehensive CBT (Cognitive Behavioral Therapy) Via reSET App
Milton S. Hershey Medical Center
NCT03826966
Reducing the Abuse Liability of Prescription Opioids
The University of Texas Health Science Center at San Antonio
NCT04587115
Safety and Tolerability of Cannabidiol Among Persons With Opioid Use Disorder Receiving Methadone or Buprenorphine
Yale University
NCT05076370
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Addiction records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Addiction trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Addiction page
17 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 5 Addiction trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Yale University sponsors the most Addiction trials on record, review their full trial history before evaluating a specific study. See Yale University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Addiction condition card totals 17 registered trials; most-linked intervention Clinic: Modified KidsNFitness; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.